Intra-Cellular Therapies Inc ITCI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:18 PM EDT
34.93quote price arrow up+0.60 (+1.75%)
Volume
82,649
52 week range
17.26 - 44.80

...

Loading . . .
  • Open34.42
  • Day High35.38
  • Day Low34.30
  • Prev Close34.33
  • 52 Week High44.80
  • 52 Week High Date06/23/21
  • 52 Week Low17.26
  • 52 Week Low Date09/02/20

Key Stats

  • Market Cap2.836B
  • Shares Out81.20M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change10.27

KEY STATS

  • Open34.42
  • Day High35.38
  • Day Low34.30
  • Prev Close34.33
  • 52 Week High44.80
  • 52 Week High Date06/23/21
  • 52 Week Low17.26
  • 52 Week Low Date09/02/20
  • Market Cap2.836B
  • Shares Out81.20M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change10.27

RATIOS/PROFITABILITY

  • EPS (TTM)-3.16
  • P/E (TTM)-11.06
  • Fwd P/E (NTM)-10.62
  • EBITDA (MRQ)-234.855M
  • ROE (MRQ)-44.57%
  • Revenue (MRQ)37.61M
  • Gross Margin (MRQ)91.28%
  • Net Margin (MRQ)-617.78%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Intra-Cellular Therapies Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company is discovering and developing drugs for the treatment of neurological and psychiatric disorders. Lumateperone (also known as ITI-007)...
Lawrence Hineline CPA
Chief Financial Officer
Michael Halstead J.D.
Executive Vice President
Mark Neumann CPA
Executive Vice President
Address
430 E 29th St
New York, NY
10016-8367
United States

Top Peers

SYMBOLLASTCHG%CHG
BCRX
BioCryst Pharmaceuticals Inc
16.40+0.28+1.74%
ALLO
Allogene Therapeutics Inc
22.54+0.59+2.69%
SAVA
Cassava Sciences Inc
84.86+15.33+22.05%
TPTX
Turning Point Therapeutics Inc
64.41+0.59+0.92%
AGIO
Agios Pharmaceuticals Inc
48.34+0.25+0.52%